ABC Transfer secures €3 million in series A financing round
Tours, France, June 29, 2020 – ABC Transfer, an industrial designer and manufacturer of secure Rapid Transfer Systems (RTS) for the biopharmaceutical industry, today announces it has raised €3 million ($3.2M) in a series A financing round. Go Capital, an investment fund management company and representative of the Loire Valley Invest Fund, led the round; with Bpifrance, the French national bank, and the regional government of Centre-Val de Loire contributing grants and loans.
The success of this first tranche of funding reflects investor confidence in ABC Transfer’s business model and leadership team, as well as strong interest in the market opportunities that its aseptic transfer systems will be addressing. Growth of the pharmaceutical industry and the rise in research and development are likely to drive the demand for aseptic filling, thus boosting the global aseptic transfer system market. The drug manufacturing shift to smaller and more flexible production lines is expected to impact growth for these systems.
ABC Transfer will use the funds to accelerate the development of its ABC Transfer® system, that improves 50 features, launch in Q4/2020 a new brand of Rapid Transfer Ports (RTP), especially designed for the biopharmaceutical industry, and gear up production. It will also strengthen its R&D activities, maintaining a budget of at least 15% of its turn-over over the long term.
“ABC Transfer is thrilled to have secured this investment. We would like to thank Go Capital, Bpifrance, the Centre-Val de Loire region and the Metropole de Tours for their support, confidence in our leadership and long-term commitment to our project,” said Thierry Girard, CEO of ABC Transfer. “Achieving this strong financial backing means that we will be able to roll out a complete range of Rapid Transfer System solutions, eagerly awaited by customers, and position our products as true innovations within biopharmaceuticals. The benefits of our high-performance and ergonomic designs include ultra-cleanliness, GMP compliance, safety and security. We look forward to raising awareness with customers of these and a host of revolutionary RTS system features.”
The safe manufacture of pharmaceutical drugs requires perfectly sterile and particle-free environments. An RTP, which consists of special double containment doors that are integrated into an isolator, is a system that allows the safe transfer of substances used in drug development, such as Active Pharmaceutical Ingredients (API) or vaccines.
ABC Transfer collaborated with a network of nine GMP industrial partners on resolving 50 shortcomings within its design that customers in production and maintenance identified in a feasibility study as deficient in currently available RTP and RTS solutions. Designed from scratch and protected by 12 patents, the ABC Transfer system is the very first of its kind to satisfy all the demands in RTS for biopharmaceutical manufacturing.
‘Go Capital is proud to accompany ABC Transfer’s management team on this project. It is set to become one of the major manufacturers of equipment and consumables for aseptic transfer chains, thanks to its significant breakthrough in innovation and large portfolio of patents,” said Herve Bachelot-Lallier, investment director of Go Capital. “The rich experience of the team, the dynamics of the sector and the need for quality in the pharmaceutical industry are assets favorable to ABC Transfer’s success.’’
ABC Transfer was co-founded in June 2019 by Thierry Girard, who is also its CFO and CCO, and Jean-Luc Schneider, its COO and CTO. They have decades of technical and executive management experience in the life sciences, specifically in RTS solutions.
Customers are currently sampling products. ABC Transfer plans to launch its first product in the fall.
Financial advisors to ABC Transfer: Multeam, Paris
Legal advisors to ABC Transfer: Steering Legal, Paris
Legal advisors to Investors: M.C. Derosne, lawyer
About Go Capital
Go Capital is the leading seed and venture capital investment fund company for innovative companies located in the Grand Ouest region of France: Brittany, Pays de la Loire, Normandy and the Centre-Val de Loire. It manages a fund portfolio of close to €200 million ($223.5M) and has invested in over 100 companies that exhibit high-growth potential in the medical field (medtech and biotech), deep tech (industry and energy transition), digital and innovative services.
The Loire Valley Invest Fund, launched in April 2017, is endowed with €21.5 million ($24M) and is subscribed by Bpifrance, the Centre Val de Loire Region, the metropolis of Orleans and Tours, banking partners (Crédit Agricole Centre Loire, Caisse d’Epargne Loire Centre, Banque Populaire Val de France, BNP Paribas), and industrial and institutional partners (Groupama Paris Val de France, THELEM Assurances, EDF, Michelin, Revicentre).
About Bpifrance
Bpifrance finances all sizes of businesses and offers a continuum of solutions adapted to every key step in a business’ growth such as: business creation, financing, guarantees or equity investment. Bpifrance has become the one-stop shop for entrepreneurs with a comprehensive toolbox (coaching, network and events, accelerators) offered to customers in the field through 50 local branches. It also finances small-caps and mid-caps to help those who need it to face their challenges and want to grow as quickly as possible.
About the Centre Val de Loire region
The Centre Val de Loire region, near Paris, is at the center of Europe’s leading cluster for pharmaceuticals, producing 50% of the drugs made in France. For many years, the regional council has accompanied developments in pharma and biotech with particular attention to biomedicines, a key element in this sector. With the extent of ABC Transfer’s technological contributions in bioproduction and the extraordinary qualities of the project and executive team, the regional council and its development agency Dev’UP fully support the set up and development of this project, notably providing financing for research and development.
Biomedicines in the Centre Val de Loire
About ABC Transfer
ABC Transfer is an industrial designer and manufacturer of secure Rapid Transfer Systems (RTS) for the biopharmaceutical industry. It provides the ultimate sterile and particle-free environment for safe drug manufacturing and bioprocessing; ensuring GMP compliance, ultra-cleanliness and enhanced ergonomic safety. Its system consists of future-proof alpha doors, beta containers, single-use bags and other superior quality sterile processing accessories based on 12 patented designs. The ABC Transfer system is the first to satisfy 50 improvement criteria, all challenges that customers worldwide have sought to resolve. Led by an executive team of pharma transfer solution experts with decades of technical and managerial experience, the company is gearing up to launch its first product in Q4/2020. The team collaborates with both pharmaceutical and isolator companies on product design and engages with a network of nine GMP industrial partners on product manufacturing. Founded in June 2019, ABC Transfer has raised €3.8M ($4.12M) in financing to date. It is located in Tours, France.
Editor Details
-
Company:
- Andrew Lloyd Associates
- Website:
